NCT05104567 2025-09-24A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)SanofiPhase 2 Completed138 enrolled 32 charts
NCT03319459 2021-11-22FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid TumorsFate TherapeuticsPhase 1 Completed44 enrolled